Lv1
50 积分 2025-11-16 加入
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
14小时前
待确认
Role of the microbiota in response to and recovery from cancer therapy
2天前
已完结
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
2天前
已完结
Gut microbiome in HCC - Mechanisms, diagnosis and therapy
2天前
已完结
Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects
2天前
已完结
Hepatocellular carcinoma
2天前
已完结
The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer
28天前
已完结
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α
1个月前
已完结
Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7
1个月前
已完结
Microbiota and metabolites modulation of cancer stem cells and chemotherapy sensitivity
1个月前
已完结
皖公网安备34019202002308
